PARIS, April 3 (Reuters) - France’s Sanofi-Aventis (SASY.PA) plans to buy Brazilian generic drugmaker Medley next week for about $700 million, Le Figaro reported in a preview of its weekend edition without saying where it obtained the information.
PARIS, April 3 (Reuters) - France’s Sanofi-Aventis (SASY.PA) plans to buy Brazilian generic drugmaker Medley next week for about $700 million, Le Figaro reported in a preview of its weekend edition without saying where it obtained the information.
